Despite the presence of two independent tumor lineages and as many as five distinct clones, no new diagnostic, prognostic, or therapeutically applicable SNVs or CNVs were found in any clones beyond the SMARCB1 events. The gene discussed is SMARCB1; the disease is neoplasm.